Industry Veteran Previous Served as EVP & Chief Commercial Officer of Illumina  MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that it has appointed industry veteran Christian Henry to its Board of Directors. Mr. Henry has over 20 years of leadership experience, including over […]

Proceeds to fund further development of breakthrough DNA sequencing platform SAN DIEGO — Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has raised an additional $60 million with the completion of its Series B financing.  The funding round was led by Decheng Capital and Hillhouse Capital Group, joined by Lam Research Capital and […]

BD® AbSeq Assay Enables Deeper Understanding of Role Individual Cells Play in the Immune System FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD® AbSeq assay to analyze protein expression at the single-cell level using high-throughput sequencing. The assay brings together high-quality antibodies from […]

BEVERLY, Mass. — LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, today announced that it has entered into the beta stage of product development of its flagship pathogen detection system.  The Company recently completed a $5.7M equity financing through a bought deal short-form prospectus offering that included a fully-subscribed […]

Making genomics and artificial intelligence (AI) technologies work together can spot the origin of a genetic mutation causing cancer or a particular condition so that the treatment can be provided on time. Predicting treatment responses in cancer patients by integrating genomics and artificial intelligence is going to become a reality. A major collaborative research project “Artificial Intelligence […]

IRVINE, Calif. — Zymo Research Corp. has announced the appointment of Joseph R. Ecker, Ph.D., to Zymo Research’s Scientific Advisory Board. Dr. Ecker serves as Professor of Plant Molecular and Cellular Biology Laboratory and Director of the Genomic Analysis Laboratory at the Salk Institute for Biological Studies located in La Jolla, CA. He is also an Investigator for the Howard […]

Mick Messman Brings Over 20 Years of Global Agricultural Sales, Marketing, Product Development and Operations Experience to GreenLight MEDFORD, Mass. — GreenLight Biosciences, Inc., a biotechnology company developing RNA-based products for agricultural and pharmaceutical applications, today announced that Mick Messman has joined the Company as Chief Commercial Officer. Mr. Messman has over 20 years of global agricultural sales, […]

Streamlines genome interpretation to improve the utility of genomic data Illumina, Inc. announces the release of open source, novel artificial intelligence (AI) software that can distinguish between potential disease-causing mutations, and the millions of benign genetic variants in individuals. The new AI software for genome interpretation has been publicly released through Illumina’s BaseSpace Sequence Hub and GitHub. […]

MENLO PARK, Calif.–Quantapore Inc. announced the appointment of Dr. Alex Dickinson and Robert Proulx to the Board of Directors. Both Directors bring a wealth of experience in the development and commercialization of new technologies and operating high-growth businesses. Alex and Bob join Dr. Martin Huber and Dr. Sascha Dennstedt, Quantapore’s co-founders as well as Feng […]

La Vista, NE – Streck, Inc. and Cromoion SRL, a distributor of human and veterinary diagnostic products in Argentina, have signed a three-year distribution agreement for Streck’s full portfolio of controls, cell stabilization and molecular products. Streck’s cell stabilization products include Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens for […]